UK Explores Libido-Suppressing Drugs for Sex Offenders, Eye Drops Recalled

The UK is considering a significant expansion of libido-suppressing drug treatments for thousands of male prisoners convicted of sex offenses. This initiative, aimed at managing problematic sexual arousal, could be rolled out to an additional 20 prisons by late 2028, potentially impacting around 3,750 inmates. Experts suggest this voluntary treatment could become a more widespread option for managing offenders.

In parallel, a large-scale recall of Clear Eyes Maximum Itchy Eye Relief eye drops is underway in the United States. Approximately 40,000 bottles are being removed from shelves due to concerns about sterility, a situation classified by the FDA as a moderate-risk recall. This action highlights ongoing challenges in ensuring product safety and efficacy within the pharmaceutical sector.